Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323037852> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W4323037852 endingPage "501" @default.
- W4323037852 startingPage "498" @default.
- W4323037852 abstract "Guillain-Barré syndrome (GBS) is a rare acute idiopathic demyelinating polyneuropathy that causes bilateral, symmetrical, and progressive weakness of muscles. AstraZeneca vaccine is a genetically modified spike glycoprotein vaccine of an adenovirus vector. GBS following the second dose of the AstraZeneca vaccine dose is rare and not frequently noted.A 78-year-old male presented to the hospital with complaints of bilateral weakness of the lower limbs over 4 days following the second dose of the AstraZeneca vaccine. On examination, the power and tone of the limbs were diminished. The sensitivity pinprick test revealed low sensitivity in the right lower limb than in the left lower limb. Nerve conduction studies revealed acute inflammatory demyelinating polyneuropathy and the patient was diagnosed with GBS. After admission, the patient was successfully treated with intravenous immunoglobulins along with physiotherapy.GBS can be diagnosed clinically with nerve conduction studies and Brighton's criteria. The robust causal relationships between COVID-19 infections, COVID-19 vaccination, and GBS are still unclear. The evaluation of the potential association and risk of GBS with vaccines warrants the need for precise post-vaccination surveillance measures and results.Only a few cases of GBS following the second dose of AstraZeneca are reported so far and there is a need for strong and accurate diagnosis of the disease and proper post-vaccination surveillance for the evaluation of risk associated with COVID vaccines." @default.
- W4323037852 created "2023-03-04" @default.
- W4323037852 creator A5019080044 @default.
- W4323037852 creator A5042674727 @default.
- W4323037852 creator A5047198398 @default.
- W4323037852 creator A5055997254 @default.
- W4323037852 creator A5086236237 @default.
- W4323037852 date "2023-02-17" @default.
- W4323037852 modified "2023-10-01" @default.
- W4323037852 title "Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal" @default.
- W4323037852 cites W1985648558 @default.
- W4323037852 cites W2033644132 @default.
- W4323037852 cites W2082865191 @default.
- W4323037852 cites W2335127767 @default.
- W4323037852 cites W3029794007 @default.
- W4323037852 cites W3103171760 @default.
- W4323037852 cites W3111303973 @default.
- W4323037852 cites W3111590711 @default.
- W4323037852 cites W3143840597 @default.
- W4323037852 cites W3170053887 @default.
- W4323037852 cites W3172281322 @default.
- W4323037852 cites W3211321564 @default.
- W4323037852 cites W4211083796 @default.
- W4323037852 cites W4224879662 @default.
- W4323037852 cites W4295498029 @default.
- W4323037852 doi "https://doi.org/10.1097/ms9.0000000000000193" @default.
- W4323037852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36923770" @default.
- W4323037852 hasPublicationYear "2023" @default.
- W4323037852 type Work @default.
- W4323037852 citedByCount "0" @default.
- W4323037852 crossrefType "journal-article" @default.
- W4323037852 hasAuthorship W4323037852A5019080044 @default.
- W4323037852 hasAuthorship W4323037852A5042674727 @default.
- W4323037852 hasAuthorship W4323037852A5047198398 @default.
- W4323037852 hasAuthorship W4323037852A5055997254 @default.
- W4323037852 hasAuthorship W4323037852A5086236237 @default.
- W4323037852 hasBestOaLocation W43230378521 @default.
- W4323037852 hasConcept C126322002 @default.
- W4323037852 hasConcept C141071460 @default.
- W4323037852 hasConcept C187212893 @default.
- W4323037852 hasConcept C203014093 @default.
- W4323037852 hasConcept C22070199 @default.
- W4323037852 hasConcept C2776418732 @default.
- W4323037852 hasConcept C2778691916 @default.
- W4323037852 hasConcept C2779134260 @default.
- W4323037852 hasConcept C2780247198 @default.
- W4323037852 hasConcept C3008058167 @default.
- W4323037852 hasConcept C524204448 @default.
- W4323037852 hasConcept C71924100 @default.
- W4323037852 hasConceptScore W4323037852C126322002 @default.
- W4323037852 hasConceptScore W4323037852C141071460 @default.
- W4323037852 hasConceptScore W4323037852C187212893 @default.
- W4323037852 hasConceptScore W4323037852C203014093 @default.
- W4323037852 hasConceptScore W4323037852C22070199 @default.
- W4323037852 hasConceptScore W4323037852C2776418732 @default.
- W4323037852 hasConceptScore W4323037852C2778691916 @default.
- W4323037852 hasConceptScore W4323037852C2779134260 @default.
- W4323037852 hasConceptScore W4323037852C2780247198 @default.
- W4323037852 hasConceptScore W4323037852C3008058167 @default.
- W4323037852 hasConceptScore W4323037852C524204448 @default.
- W4323037852 hasConceptScore W4323037852C71924100 @default.
- W4323037852 hasIssue "3" @default.
- W4323037852 hasLocation W43230378521 @default.
- W4323037852 hasLocation W43230378522 @default.
- W4323037852 hasLocation W43230378523 @default.
- W4323037852 hasLocation W43230378524 @default.
- W4323037852 hasOpenAccess W4323037852 @default.
- W4323037852 hasPrimaryLocation W43230378521 @default.
- W4323037852 hasRelatedWork W1574214757 @default.
- W4323037852 hasRelatedWork W1951761469 @default.
- W4323037852 hasRelatedWork W2022697484 @default.
- W4323037852 hasRelatedWork W2031393476 @default.
- W4323037852 hasRelatedWork W2063693311 @default.
- W4323037852 hasRelatedWork W2182054187 @default.
- W4323037852 hasRelatedWork W3021917203 @default.
- W4323037852 hasRelatedWork W3124935910 @default.
- W4323037852 hasRelatedWork W3214779882 @default.
- W4323037852 hasRelatedWork W4385388467 @default.
- W4323037852 hasVolume "85" @default.
- W4323037852 isParatext "false" @default.
- W4323037852 isRetracted "false" @default.
- W4323037852 workType "article" @default.